|
|
Keryx to commence phase-3 trial for Zerenex - Drug Store News |
|
Drug Store NewsThe company is conducting a phase-3 trial of Zerenex (ferric citrate) in patients with end-stage kidney disease on dialysis who have excessive phosphorous ...Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex ... PR Newswire (press release)Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex ... |
|
|
The United State's 50 most active renal transplant centers in 2009 - NephrOnline |
|
NephrOnlineThe United State's 50 most active renal transplant centers in 2009 listing was provided by the Organ Procurement and Transplantation Network. ... |
|
Family angry about Oakland hospital's procedural error - San Jose Mercury News |
|
San Jose Mercury NewsConstantine, a dialysis patient who would have been 48 on Nov. 11, died after seeking treatment at the hospital. The Alameda County Coroner's Office listed ... |
|
CJPS Medical Systems Launches Game Changing Product to Improve Healthcare ... - Business Wire (press release) |
|
Business Wire (press release)... hypertension, congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), and end-stage renal disease (ESRD). ... |
|
Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex ... - PR Newswire (press release) |
|
PR Newswire (press release)In the United States, according to data from the US Renal Data System, there are approximately 485000 patients with end-stage renal disease, or ESRD, ... |
|
|
|
|
<< Start < Prev 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 Next > End >>
|
|
Page 1253 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
